Oesophageal cancer

2016 ◽  
pp. 365-387
Author(s):  
Melissa Thomas ◽  
Karin Haustermans ◽  
Eric Van Cutsem ◽  
Piet Dirix ◽  
Xavier Sagaert ◽  
...  
Keyword(s):  
Oesophageal Cancer ◽  
Adjuvant Radiotherapy ◽  
Palliative Treatment ◽  
Early Stage ◽  
Locally Advanced ◽  
Adjuvant Chemoradiotherapy ◽  
Valuable Alternative ◽  
Early Stage Carcinoma

Worldwide, oesophageal cancer, including cancer of the gastro-oesophageal junction (GEJ), is the sixth leading cause of death from cancer. Despite recent advances, treatment of oesophageal cancer remains challenging and is best approached by an experienced multidisciplinary team. Surgery alone is the treatment of choice in early stage carcinoma although in superficial cancers (T1a) endoscopic resection is to be preferred. In locally advanced tumours induction therapy followed by surgery is the preferred treatment. In selected cases definitive chemoradiotherapy could be considered as a valuable alternative. The role of adjuvant chemotherapy is unclear, but could be considered for selected GEJ adenocarcinoma patients. Adjuvant chemoradiotherapy should be considered in all patients with advanced disease or positive margins who did not receive neo-adjuvant radiotherapy. For metastatic disease, the goal is to prolong and maximize quality of life. Regarding the palliative treatment of dysphagia, brachytherapy was shown to be more effective than stenting.

Oesophageal cancer

2016 ◽  
pp. 365-387
Author(s):  
Piet Dirix ◽  
Karin Haustermans ◽  
Eric Van Cutsem ◽  
Xavier Sagaert ◽  
Christophe M. Deroose ◽  
...  
Keyword(s):  
Oesophageal Cancer ◽  
Palliative Treatment ◽  
Early Stage ◽  
Locally Advanced ◽  
Adjuvant Chemoradiotherapy ◽  
Locally Advanced Tumors ◽  
Early Stage Carcinoma ◽  
Advanced Tumors

Worldwide, oesophageal cancer, including cancer of the gastro-oesophageal junction (GEJ), is the sixth leading cause of death from cancer. Despite recent advances, treatment of oesophageal cancer remains challenging and is best approached by an experienced multidisciplinary team. Surgery alone is the treatment of choice in early stage carcinoma although in superficial cancers (T1a) endoscopic resection is to be preferred. In locally advanced tumors induction therapy followed by surgery is the preferred treatment. In selected cases definitive chemoradiotherapy could be considered as a valuable alternative The role of adjuvant chemotherapy is unclear, but could be considered for selected GEJ adenocarcinoma patients. Adjuvant chemoradiotherapy should be considered in all patients with advanced disease or positive margins who did not receive neo-adjuvant radiotherapy. For metastatic disease, the goal is to prolong and maximize quality of life. Regarding the palliative treatment of dysphagia, brachytherapy was shown to be more effective than stenting.

Oesophageal cancer

2016 ◽  
pp. 365-387
Author(s):  
Piet Dirix ◽  
Reinhilde Weytjens ◽  
Sabine Vanderkam ◽  
Karin Haustermans ◽  
Eric Van Cutsem ◽  
...  
Keyword(s):  
Oesophageal Cancer ◽  
Palliative Treatment ◽  
Early Stage ◽  
Locally Advanced ◽  
Adjuvant Chemoradiotherapy ◽  
Locally Advanced Tumors ◽  
Early Stage Carcinoma ◽  
Advanced Tumors

Worldwide, oesophageal cancer, including cancer of the gastro-oesophageal junction (GEJ), is the sixth leading cause of death from cancer. Despite recent advances, treatment of oesophageal cancer remains challenging and is best approached by an experienced multidisciplinary team. Surgery alone is the treatment of choice in early stage carcinoma although in superficial cancers (T1a) endoscopic resection is to be preferred. In locally advanced tumors induction therapy followed by surgery is the preferred treatment. In selected cases definitive chemoradiotherapy could be considered as a valuable alternative The role of adjuvant chemotherapy is unclear, but could be considered for selected GEJ adenocarcinoma patients. Adjuvant chemoradiotherapy should be considered in all patients with advanced disease or positive margins who did not receive neo-adjuvant radiotherapy. For metastatic disease, the goal is to prolong and maximize quality of life. Regarding the palliative treatment of dysphagia, brachytherapy was shown to be more effective than stenting.

scholarly journals Role of Panchatikta Panchaprasutik Niruha Vasti in Prediabetes A case report

2020 ◽  
Vol 11 (3) ◽  
pp. 588-593
Author(s):  
Poonam V Ashtankar ◽  
Punam Sawarkar
Keyword(s):  
Diabetes Prevention ◽  
Palliative Treatment ◽  
Relative Risk Reduction ◽  
Early Stage ◽  
Single Case ◽  
Single Case Study ◽  
Urine Sugar

Background: Prediabetes is an intermediate state of hyperglycemia with glycaemic parameters above normal but below the diabetes threshold. In Ayurveda, it is correlated with Prameha Poovaroopavastha. The risk of developing diabetes remains high with an annual conversion rate 5-10%. Many other studies have shown that the efficacy of lifestyle intervention in diabetes prevention with a relative risk reduction of 40-70% in prediabetes adults. If we treat this disease in early stage then it checks the further pathogenesis of disease. Aim and objectives: The aim of this study was to observe the efficacy of Panchatikta Panchaprasutik Niruha Vasti enema including Palliative treatment in prediabetes. Methods: It is a single case study of 55 years old male patient who was diagnosed with prediabetes correlated as Prameha Poorvaroopa from 1 year approached to Ayurvedic hospital and was treated Panchatikta Panchaprasutik Niruha Vasti. The treatment was continued for consecutive 15 days. Results: After 15days changes were observed in symptoms as well as reduction was seen in blood and urine sugar level and overall quality of life of patient was improved. Conclusion: Patient got satisfactory relief in symptoms as well as objective parameters after 15 days.

Role of Adjuvant Radiotherapy in Early Stage Tongue Cancer: Need for Establishing Stringent Guidelines

2021 ◽  
Author(s):  
Vishal Rao ◽  
Anand Subash ◽  
Piyush Sinha ◽  
Sameep Shetty ◽  
Shalini Thakur ◽  
...  
Keyword(s):  
Adjuvant Radiotherapy ◽  
Tongue Cancer ◽  
Early Stage

A ROLE OF AYURVEDA IN THE MANAGEMENT OF APASMARA (EPILEPSY): A CASE STUDY

2021 ◽  
Vol 12 (4) ◽  
pp. 24-29
Author(s):  
Shruti . ◽  
C V Rajashekhar ◽  
Manjunatha Adiga
Keyword(s):  
Antiepileptic Drugs ◽  
Palliative Treatment ◽  
Cognitive Level ◽  
Frequent Seizure ◽  
Seizure Attack ◽  
Seizure Attacks

Apasmara (epilepsy) is defined as the apagama (deterioration) of smriti (memory) associated with bibhasta cheshta (seizures) due to derangement of dhi and satwa, mainly related to vata and rajo dosha vitiation, which effects both Sharira (body) and Mana (mind). The present antiepileptic drugs control the seizure attack, but long-term use generates adverse effect at cognitive level and leads to behavioral disorders, hence there is need of safe and effective treatment which not only controls seizure attack but helps to cure the disease. A 44-year-old man approached Kayachikitsa OPD with the complaints of frequent seizure attacks, since from at the age of one and half year with regular oral antiepileptic drugs medications (allopathic), the dose of medications increasing yearly and he was not satisfied with treatment, so he was advised with Panchakarma treatment starting from Deepana, Pachana, Vamana (medicated emesis), Virechana (medicated purgation), Basti (medicated enema), Shirodhara along with palliative treatment. After each treatment it was observed that the patient was satisfied with treatment and the complaints of seizure attack reduced in frequency and duration with improved quality of life. Palliative treatment was advised to continue along with modern medications.

scholarly journals Role of chemotherapy for early stage carcinoma of the ampulla of vater treated by pancreaticoduodenectomy – a single centre series

HPB ◽  
2016 ◽  
Vol 18 ◽  
pp. e406
Author(s):  
L. Varatharajan ◽  
M.H. Sodergren ◽  
N. Tapuria ◽  
A. Wotherspoon ◽  
J. Thompson ◽  
...  
Keyword(s):  
Early Stage ◽  
Ampulla Of Vater ◽  
Single Centre ◽  
Early Stage Carcinoma

scholarly journals The Role of Radiotherapy for Pancreatic Malignancies- A Population-based Analysis of the SEER-Medicare Database.

2020 ◽  
Author(s):  
yunxiu luo ◽  
Shengjun Xiao
Keyword(s):  
Pancreatic Cancer ◽  
Pancreatic Carcinoma ◽  
Adjuvant Radiotherapy ◽  
Adenosquamous Carcinoma ◽  
Early Stage ◽  
Pancreatic Head ◽  
Population Based ◽  
Anatomical Location ◽  
Duct Carcinoma

Abstract Background and objective. To investigate the role of adjuvant radiotherapy in patients after surgical resection for pancreatic cancer. Methods and patients. The patients with pancreatic cancer from 18 registered institutions in the Surveillance Epidemiology and End Results (SEER) database were retrospectively analyzed. The characteristics of patients who would benefit from adjuvant radiotherapy were screened, as well as whether neoadjuvant or adjuvant radiotherapy conferred to a better clinical outcome. Results. 30249 patients included in this study (21295 vs 8954 in surgery and adjuvant radiotherapy group) .The median survivals in the surgery (S) group and adjuvant radiotherapy (S+R) group were 24 and 21 months respectively, The 1, 3, and 5-year overall survival (OS) rates in the S group and S+R group were 68%, 40%, 31% ,and 75%, 30%, 20%, respectively (p<0.001).Stratified analysis showed patients with histological classified as adenocarcinoma(15 VS 21, P<0.0001), infiltrating duct carcinoma (17 VS 21,P<0.0001), adenosquamous carcinoma(10 VS 18,P<0.0001) could be benefit from adjuvant radiotherapy. Adjuvant radiotherapy was helpful to improve the OS for patients with pancreatic head (19 VS 21, P=0.0003) and duct carcinoma (18VS 28, P=0.0121). Subgroup stratified assay indicated specific patients with early stage (AJCC 7th I, II, T2, N0) pancreatic carcinoma had better OS after additional radiotherapy than surgery alone. Conclusion. Additional radiotherapy may contribute to improved prognosis for patients with pancreatic carcinoma of specific histological types (adenocarcinoma/carcinoma, infiltrating duct carcinoma, adenosquamous carcinoma, and squamous), anatomical location, and advanced stage. A specific subgroup of patients with an early stage (I/II, T2) pancreatic cancer should be considered for additional radiotherapy.

The Role of Nursing in Caring for Patients Receiving Palliative Surgery or Chemotherapy

2019 ◽  
pp. 660-669
Author(s):  
Virginia Sun ◽  
Tami Tittelfitz ◽  
Marjorie J. Hein
Keyword(s):  
Palliative Treatment ◽  
Symptom Control ◽  
Palliative Surgery ◽  
Treatment Modalities ◽  
Indications For Surgery ◽  
Role Of Nursing ◽  
Definition Of ◽  
Treatment Intent

Surgery and chemotherapy are common treatment modalities used to manage disease and symptoms in palliative settings where the disease is incurable. These treatment modalities can lead to deteriorations in a patient’s quality of life (QOL). The benefits of palliative surgery and chemotherapy should always focus on QOL, symptom control, and symptom prevention. The purpose of this chapter is to provide an overview of the definition of palliative surgery and chemotherapy, describe common indications for surgery and chemotherapy for palliative treatment intent, and discuss the role of nursing in caring for patients who are receiving palliative surgery and chemotherapy.

Sign in / Sign up

Export Citation Format

Share Document